In general, antipsychotic agents have diverse actions on a wide range of ne
urotransmitter systems. Data strongly suggest that a number of these system
s may play a role in the regulation of body weight. In addition to having v
ery distinct pharmacologic profiles, individual agents possess discrete wei
ght gain liabilities. This article briefly reviews the evidence for the inv
olvement of specific neurotransmitter systems in the control of body weight
and describes the relevant pharmacologic characteristics of individual ant
ipsychotic agents. By comparing the pharmacologic profiles of specific anti
psychotic agents with their respective weight gain liabilities, this articl
e attempts to gain an insight into the specific receptors underlying a drug
's propensity to induce weight gain. However, there is still much to be lea
rned concerning weight control mechanisms, and the role of many of the rece
ptors at which antipsychotic agents are active remains unclear. In spite of
this, an overview of current knowledge in the field may facilitate predict
ion of a potential novel antipsychotic agent's weight gain liability.